Brown Advisory’s Xeris Biopharma Holdings XERS Stock Holding History

Brown Advisory’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-114,698	Closed	-$536K	–	1424
2025 Q2	$536K	Hold	114,698	–	–	﹤0.01%	984
2025 Q1	$630K	Sell	114,698 -75,557	-40%	-$305K	﹤0.01%	926
2024 Q4	$645K	Hold	190,255	–	–	﹤0.01%	923
2024 Q3	$542K	Hold	190,255	–	–	﹤0.01%	978
2024 Q2	$428K	Hold	190,255	–	–	﹤0.01%	991
2024 Q1	$420K	Sell	190,255 -21,150	-10%	-$54.7K	﹤0.01%	984
2023 Q4	$497K	Sell	211,405 -18,100	-8%	-$33.4K	﹤0.01%	940
2023 Q3	$427K	Sell	229,505 -6,900	-3%	-$15.8K	﹤0.01%	939
2023 Q2	$619K	Hold	236,405	–	–	﹤0.01%	857
2023 Q1	$385K	Hold	236,405	–	–	﹤0.01%	975
2022 Q4	$314K	Sell	236,405 -11,749	-5%	-$16.6K	﹤0.01%	1018
2022 Q3	$387K	Hold	248,154	–	–	﹤0.01%	919
2022 Q2	$382K	Hold	248,154	–	–	﹤0.01%	906
2022 Q1	$635K	Sell	248,154 -51,600	-17%	-$126K	﹤0.01%	806
2021 Q4	$878K	Buy	+299,754	New	+$647K	﹤0.01%	753
2021 Q3	–	Sell	-299,754	Closed	-$1.22M	–	1150
2021 Q2	$1.22M	Sell	299,754 -20,000	-6%	-$76.3K	﹤0.01%	659
2021 Q1	$1.44M	Hold	319,754	–	–	﹤0.01%	639
2020 Q4	$1.57M	Hold	319,754	–	–	﹤0.01%	580
2020 Q3	$1.9M	Buy	+319,754	New	+$1.28M	﹤0.01%	524

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Brown Advisory's XERS Position: Q3 2025 in Review

Brown Advisory sold out of Xeris Biopharma Holdings (XERS) in Q3 2025, closing a stake of 114,698 shares — an estimated $536K sold.

Brown Advisory first reported a position in XERS in Q3 2020 and held it in 19 quarters. The position peaked at $1.9M in Q3 2020. 230 funds tracked by Wall St. Rank hold XERS as of Q3 2025.

Brown Advisory reported no remaining Xeris Biopharma Holdings position as of Q3 2025 after selling out during the quarter.
Brown Advisory sold 114,698 Xeris Biopharma Holdings shares in Q3 2025, an estimated $536K.
Brown Advisory first reported a position in Xeris Biopharma Holdings in Q3 2020 and held it in 19 quarters.
Brown Advisory's Xeris Biopharma Holdings position peaked at $1.9M in Q3 2020.
230 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2025.

Based on Brown Advisory's 13F filing for Q3 2025, filed 14 Nov 2025.